Non-alcoholic steatohepatitis (NASH) is a progressive liver disease characterized by inflammation, liver fibrosis, and potential cirrhosis. As the prevalence of NASH rises globally, it has become a major health concern. Despite the growing need for effective treatments, there are currently no FDA-approved therapies specifically for NASH. However, the landscape is shifting as researchers...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)